Publication:
Targeting NRF2 to suppress ferroptosis in brain injury

Thumbnail Image
Files
Song-36-383-397-2021.pdf(4.55 MB)
Date
2021
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Song, Shunchen ; Gao, Yaxuan ; Sheng, Yi ; Rui, Tongyu ; Luo, Chengliang
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-286
item.page.type
info:eu-repo/semantics/article
Description
Abstract
y. Brain injury is accompanied by serious iron metabolism disorder and oxidative stress. As a novel form of regulated cell death (RCD) depending on lipid peroxidation caused by iron overload, ferroptosis (FPT) further aggravates brain injury, which is different from apoptosis, autophagy and other traditional cell death in terms of biochemistry, morphology and genetics. Noteworthy, transcriptional regulator NRF2 plays a key role in the cell antioxidant system, and many genes related to FPT are under the control of NRF2, including genes for iron regulation, thiol-dependent antioxidant system, enzymatic detoxification of RCS and carbonyls, NADPH regeneration and ROS sources from mitochondria or extra-mitochondria, which place NRF2 in the key position of regulating the ferroptotic death. Importantly, NRF2 can reduce iron load and resist FPT. In the future, it is expected to open up a new way to treat brain injury by targeting NRF2 to alleviate FPT in brain.
publication.page.subject
Nuclear Factor Erythroid , Related Factor , (NRF2) , Brain Injury , Ferroptosis (FPT)
Citation
URI
http://hdl.handle.net/10201/127106
item.page.embargo
Collections
Histology and histopathology Vol.36, nº4 (2021)
Ir a Estadísticas